Built by Clinicians. Grounded in Data.
AGRI was founded because the gap between what patients feel and what clinicians can measure has always carried a clinical cost. We closed that gap.
The Problem Preceded the Device
Anesthesiologists and pain specialists have long made critical dosing decisions based on a patient pointing to a number. Our founders — clinicians and EEG researchers — experienced the downstream consequences: over-sedation, undertreated pain, inconsistent outcomes.
AGRI was incorporated with a single clinical mandate: produce a continuous, standardized pain index derived from EEG signal — not patient recall, not nurse observation, not a 0-to-10 scale.
Pain data should be as objective as vital signs
Heart rate, blood oxygen, intracranial pressure — all measured continuously and objectively. Pain remained the exception. AGRI's mission is to end that exception with EEG-derived, standardized scoring.






Three disciplines. One organization.
Clinical Medicine
EEG Signal Processing
FDA Regulatory Affairs
Practicing anesthesiologists and pain specialists who defined the clinical requirements and validated AGRI's index against patient outcomes in real care settings.
Neuroscientists and biomedical engineers who developed the recurrent indexing algorithm that converts raw cortical signal into a continuous, graded 0-100 AGRI score.
Specialists in Class II and Class III medical device pathways who oversee AGRI's FDA 510(k) submission track and ensure clinical study protocols meet regulatory standards.
Clinical partnerships and investor inquiries are reviewed directly by our leadership team.
